Beata Marciniak
Medical University of Lublin
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Beata Marciniak.
Current Pharmaceutical Biotechnology | 2011
Beata Marciniak; Jolanta Patro-Małysza; Elżbieta Poniedziałek-Czajkowska; Zaneta Kimber-Trojnar; Bożena Leszczyńska-Gorzelak; Jan Oleszczuk
The fetus may be exposed to increased endogenous or synthetic glucocorticoid (GS) exposure in late gestation. Approximately 7% of pregnant women in Europe and North America are treated with synthetic GSs to promote lung maturation in fetuses at risk of preterm delivery. Maternal steroid treatment before preterm delivery is one of the best documented and most cost effective life saving treatments in prenatal medicine but, in certain circumstances, the price of accelerated lung maturity may be loss of brain cells, increased neurodevelopmental disability, intra-uterine growth restriction (IUGR), and an increased risk of preterm delivery, of programming of post-natal hypertension, and of increased post-natal activity in the hypothalamo-pituitary-adrenal (HPA) axis. Placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) is the key enzyme which protects the fetus from overexposure to GSs by their oxidation into inactive derivates. We review the evidence for the metabolism of GSs during pregnancy and how endogenous and synthetic GSs cause other changes in the placenta which affect fetal development.
Journal of Maternal-fetal & Neonatal Medicine | 2010
Żaneta Kimber-Trojnar; Jolanta Patro-Małysza; Bożena Leszczyńska-Gorzelak; Beata Marciniak; Jan Oleszczuk
Objective. To evaluate the efficacy and safety of polyvinyl chloride pessary in patients with cervical incompetence or at risk of preterm labour. Methods. Study was conducted on 56 pregnant women who were treated with pessary and delivered in the Department of Obstetrics and Perinatology in Lublin during a half-year period. Statistical evaluation included Spearman correlation analysis and Wilcoxon signed-rank test. Results. The mean gestational age at pessary insertion was 23 weeks gestation. Pessary was electively removed after 37 weeks gestation. The mean interval between pessary insertion and delivery was 13 weeks, the mean gestational age at delivery 38.3 weeks and birth weight was 3255 g. Two (3.6%) women delivered before 34 weeks. A total of 58 live infants was born. No significant complications that could be attributed to pessary use were observed. Conclusions. Pessary may be useful in women with cervical incompetence or at risk of preterm labour.
Current Pharmaceutical Biotechnology | 2011
Elżbieta Poniedziałek-Czajkowska; Beata Marciniak; Zaneta Kimber-Trojnar; Bożena Leszczyńska-Gorzelak; Jan Oleszczuk
Nitric oxide (NO) is a key molecule involved in a variety of biological functions throughout the whole body. Many studies have been devoted to establish the role of NO in perinatal medicine and the different findings have promoted the clinical use of NO donors as new pharmacological tools. NO regulates the vascular tone and blood flow by activating soluble guanylate cyclase in the vascular smooth muscles. NO is essential for leukocyte adhesion and platelet aggregation, and it controls mitochondrial oxygen consumption. Abnormalities in vascular NO production and transport result in endothelial dysfunction with various cardiovascular disorders such as hypertension, atherosclerosis and angiogenesis-associated disorders. The NO system has important roles in mammalian reproductive physiology, especially in the utero-placental system. It has been shown to participate in the extravillous trophoblast invasion of decidua and myometrium, in regulation of vascular reactivity of utero-placental and fetal-placental circulations, in prevention of platelet and neutrophil aggregation and adhesion in the intervillous space, and in trophoblast apoptosis. The aim of this review is to present the theoretical background and significance of NO in normal and preeclamptic pregnancy as well as to consider how NO donors could be useful in clinical practice.
Taiwanese Journal of Obstetrics & Gynecology | 2017
Aleksandra Marciniak; Jolanta Patro-Małysza; Żaneta Kimber-Trojnar; Beata Marciniak; Jan Oleszczuk; Bożena Leszczyńska-Gorzelak
Prenatal development is currently recognized as a critical period in the etiology of human diseases. This is particularly so when an unfavorable environment interacts with a genetic predisposition. The fetal programming concept suggests that maternal nutritional imbalance and metabolic disturbances may have a persistent and intergenerational effect on the health of offspring and on the risk of diseases such as obesity, diabetes, and cardiovascular diseases.
Twin Research and Human Genetics | 2014
Katarzyna Kosinska-Kaczynska; Iwona Szymusik; Dorota Bomba-Opoń; Anna Madej; Jan Oleszczuk; Jolanta Patro-Małysza; Beata Marciniak; Grzegorz H. Bręborowicz; Krzysztof Drews; Agnieszka Seremak-Mrozikiewicz; Marta Szymankiewicz; Mariusz Zimmer; Michał Pomorski; Anita Olejek; Helena Sławska; Miroslaw Wielgos
The study aimed at investigating the impact of late prematurity (LPT) on neonatal outcome in twins and neonatal morbidity and mortality within LPT with regard to the completed weeks of gestation. The study was conducted in six tertiary obstetric departments from different provinces of Poland (Warsaw, Lublin, Poznan, Wroclaw, Bytom). It included 465 twin deliveries in the above centers in 2012. A comparative analysis of maternal factors, the course of pregnancy and delivery and neonatal outcome between LPT (34 + 0-36 + 6 weeks of gestation) and term groups (completed 37 weeks) was performed. The neonatal outcome included short-term morbidities. The analysis of neonatal complication rates according to completed gestational weeks was carried out. Out of 465 twin deliveries 213 (44.8%) were LPT and 156 (33.55%) were term. There were no neonatal deaths among LPT and term twins. One-third of LPT newborns suffered from respiratory disorders or required antibiotics, 40% had jaundice requiring phototherapy, and 30% were admitted to NICU. The analysis of neonatal morbidity with regard to each gestational week at delivery showed that most analyzed complications occurred less frequently with the advancing gestational age, especially respiratory disorders and NICU admissions. The only two factors with significant influence on neonatal morbidity rate were neonatal birth weight (OR = 0.43, 95% CI = 0.2-0.9, p = .02) and gestational age at delivery (OR = 0.62, 95% CI = 0.5-0.8, p < .01). LPT have a higher risk of neonatal morbidity than term twins. Gestational age and neonatal birth weight seem to play a crucial role in neonatal outcome in twins.
Current Pharmaceutical Biotechnology | 2014
Jolanta Patro-Małysza; Zaneta Kimber-Trojnar; Katarzyna Skorzynska-Dziduszko; Beata Marciniak; Dorota Darmochwal-Kolarz; Jacek Bartosiewicz; Bożena Leszczyńska-Gorzelak; Jan Oleszczuk
Gestational diabetes mellitus is one of the most often medical conditions during pregnancy affecting 5-6% of all pregnancies. The etiology of gestational diabetes is not clearly understood. In obesity and diabetes mellitus type 2, abnormal insulin signaling is an important agent mediating the increase of insulin resistance. Insulin receptor substrate serine phosphorylation is a time-controlled physiological reaction in insulin signaling that has been disrupted by metabolic and inflammatory stresses to support insulin resistance. Several kinases, including inhibitor of nuclear factor ĸB kinase β (IKK β), c-Jun N-terminal kinase (JNK), mammalian target of rapamycin (mTOR), protein kinase C (PKC) and ribosomal S6 protein kinase (S6K), are activated by these stimulators of insulin resistance and phosphorylate insulin receptor substrate proteins on several serine residues in an uncontrollable method. There are an increasing number of data indicating that substance P, being one of the crucial activators of these kinases, is a potent cytokine that impairs insulin signaling. Here we discuss recent studies that expand our understanding of how substance P may contribute to the development of insulin resistance. In our opinion, there are many interesting data suggesting that substance P may be a new player in the pathogenesis of this unfavorable condition, leading not only to the development of diabetes mellitus type 2, but also gestational diabetes. Since the etiology of gestational diabetes remains unclear, there is a strong need to explore new directions, including those not directly associated with the canonical knowledge regarding this pathology.
Journal of Maternal-fetal & Neonatal Medicine | 2018
Beata Marciniak; Jolanta Patro-Małysza; Żaneta Kimber-Trojnar; Jan Oleszczuk; Bożena Leszczyńska-Gorzelak
Abstract Purpose: The aim of this paper is to identify predictors of cesarean delivery (CD) in patients with an unfavorable cervix undergoing cervical ripening and labor induction with Foley catheter. Materials and methods: A retrospective cohort study of singleton pregnancies induced using Foley catheter was performed to evaluate whether factors in the maternal history and during the process of labor induction are useful in predicting the risk of CD. Results: During the study period there were 2221 births in the Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland. From a cohort of 402 women with Foley catheter induction (FCI), 327 met inclusion criteria. There were 236 vaginal labors (72.2%) and 91 CDs (27.8%). Nulliparity (OR 2.344), Bishop score of 1–2 points (OR 1.473), and meconium-stained amniotic fluid (OR 1.980) are linked to the risk of CD. In nulliparous patients, factors associated with an increased risk of CD included maternal age greater than 30 years (OR 3.200), meconium-stained amniotic fluid (OR 2.505), and birthweight ≥3400 g (OR 1.803). Among multiparous women none of the evaluated factors was significantly connected to CD. Conclusions: Nulliparity, low Bishop score, and meconium-stained amniotic fluid are important risk factors of CD after FCI.
Ginekologia Polska | 2016
Katarzyna Kosinska-Kaczynska; Iwona Szymusik; Dorota Bomba-Opoń; Anita Olejek; Helena Sławska; Mariusz Zimmer; Michał Pomorski; Grzegorz H. Bręborowicz; Krzysztof Drews; Agnieszka Seremak-Mrozikiewicz; Marta Szymankiewicz; Tomasz Pikuła; Jan Oleszczuk; Jolanta Patro-Małysza; Beata Marciniak; Mirosław Wielgoś
OBJECTIVES The aim of the study was to analyze the perinatal outcome of twin gestations and estimate the influence of chorionicity on the outcome in a large cohort of twin pregnancies in Poland. MATERIAL AND METHODS A retrospective analysis of 465 twin deliveries in 6 Polish centers in 2012 was conducted. Baseline characteristics, the course of pregnancy and labor, as well as the neonatal outcome were analyzed in the study group and according to chorionicity. RESULTS A total of 356 twin pregnancies were dichorionic (DC group) (76.6%), and 109 were monochorionic (MC group) (23.4%). There were no differences in the occurrence of pregnancy complications according to chorionicity, except for IUGR of at least one fetus (MC 43.1% vs. DC 34.6%; p = 0.003). 66.5% of the women delivered preterm, significantly more in the MC group (78% vs. 62.9%; p = 0.004). Cesarean delivery was performed in 432 patients (92.9%). Mean neonatal birthweight was statistically lower in the MC group (2074 g vs. 2370 g; p < 0.001). Perinatal mortality of at least one twin was 4.3% (2.8% in the DC group vs. 9.2% in the MC group; p = 0.004). Neonatal complications, including NICU admission, respiratory disorders, and infections requiring antibiotic therapy, were significantly more often observed among the MC twins. CONCLUSIONS The overall perinatal outcome in the presented subpopulation of Polish twins and its dependence on cho-rionicity is similar to the reports in the literature. Nevertheless, the rates of preterm and cesarean deliveries remain higher. It seems that proper counselling of pregnant women and education of obstetricians may result in reduction of these rates.
Ginekologia Polska | 2011
Beata Marciniak; Kimber-Trojnar Z; Bożena Leszczyńska-Gorzelak; Jolanta Patro-Małysza; Trojnar M; Jan Oleszczuk
Current Pharmaceutical Biotechnology | 2014
Zaneta Kimber-Trojnar; Beata Marciniak; Jolanta Patro-Małysza; Katarzyna Skorzynska-Dziduszko; Elżbieta Poniedziałek-Czajkowska; Radzisław Mierzyński; Krzysztof Gałczyński; Marcin P. Trojnar; Bożena Leszczyńska-Gorzelak; Jan Oleszczuk